Obsidio, Inc. is an early-stage medical device company focused on developing a minimally-invasive occlusive agent using a shear-thinning biomaterial (STB) technology for applications in vascular embolotherapy.
Location: United States, South Carolina
Member count: 1-10
Total raised: $3M
Founded date: 2018
Investors 2
Date | Name | Website |
- | Charleston... | chapsc.com |
- | Good Growt... | goodgrowth... |
Funding Rounds 1
Date | Series | Amount | Investors | Deal News |
07.08.2020 | Grant | $3M | - | finsmes.co... |
Mentions in press and media 1
Date | Title | Description | Category | Author | Source |
07.08.2020 | Obsidio Cl... | Obsidio, Inc., a Columbia, S.C... | USA | - | finsmes.co... |